Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2014
06/12/2014WO2014089290A1 Crispr-based genome modification and regulation
06/12/2014WO2014088106A1 Prophylactic or therapeutic agent for fibromyalgia
06/12/2014WO2014087904A1 Agent for preventing or treating osteoclast-induced disease
06/12/2014WO2014086960A1 Triazine formulations with a second active ingredient and surfactant(s)
06/12/2014WO2013192274A9 Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
06/12/2014US20140163451 Methods and Compositions for Treating Conditions of the Eye
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163105 Topical preparation for pain relief
06/12/2014US20140163093 METHODS FOR TREATING INFLAMATORY CONDITIONS AND STATES, AND CANCERS BY ANTAGONIZING NF-kB ACTIVATION
06/12/2014US20140163088 Compounds, composition, methods, targets for cancer therapy
06/12/2014US20140163066 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
06/12/2014US20140163055 Methods and compositions of treating hiv infection
06/12/2014US20140163054 Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders
06/12/2014US20140163050 Use of 1H-quinazoline-2,4-diones
06/12/2014US20140163045 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use
06/12/2014US20140163033 Pyrrolotriazinone derivatives as p13k inhibitors
06/12/2014US20140163025 Indanyloxydihydrobenzofuranylacetic acids
06/12/2014US20140163012 Pyrido-/azepino-benzofuran and pyrido-/azepino-benzothiophene mch-1 antagonists, methods of making, and use thereof
06/12/2014US20140163004 Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase Inhibitors
06/12/2014US20140162996 Novel modulators of development of adipocyte and cancer cells
06/12/2014US20140162994 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
06/12/2014US20140162992 Topical application of dihydrotestosterone for promoting hair growth containing formulations
06/12/2014US20140162981 Substituted aryloxazoles and their use
06/12/2014US20140162971 Bromodomain inhibitors
06/12/2014US20140162964 Use in brain degenerative diseases
06/12/2014US20140162942 Inhibition of cyp3a drug metabolism
06/12/2014US20140162937 Polymyxin derivatives and uses thereof
06/12/2014US20140162874 Pesticidal compositions and processes related thereto
06/12/2014US20140161912 Compositions and methods for tissue regeneration
06/12/2014US20140161906 Use of angiogenesis antagonists in conditions of abnormal venous proliferation
06/12/2014US20140161896 Particles for the treatment of neurodegenerative diseases
06/12/2014US20140161887 Adjuvant compositions
06/12/2014US20140161882 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
06/12/2014US20140161839 Aminophosphinic derivatives that can be used in the treatment of pain
06/12/2014US20140161830 Amine-containing lipidoids and uses thereof
06/12/2014US20140161828 Bcma antigen binding proteins
06/12/2014US20140161824 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
06/12/2014US20140161820 Short-Term Surrogate Test for Investigative Drugs
06/12/2014US20140161819 Compositions Comprising Anti-CD38 Antibodies and Lenalidomide
06/12/2014US20140161816 Anti- tnf antibodies, compositions, methods and uses
06/12/2014US20140161813 Methods for the diagnosis, treatment and monitoring of cancer
06/12/2014US20140161804 Bispecific immunobinders directed against tnf and il-17
06/12/2014US20140161801 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
06/12/2014US20140161798 Anti-pcsk9 and methods for treating lipid and cholesterol disorders
06/12/2014US20140161794 Anti-vla-4 antibodies
06/12/2014US20140161786 Therapeutic compositions and related methods
06/12/2014US20140161785 Verticillin A Inhibition of Histone Methyltransferases
06/12/2014US20140161770 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
06/12/2014US20140161769 Methods for treating inflammatory autoimmune disorders
06/12/2014US20140161767 Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same
06/12/2014US20140161749 Compositions and methods for treating purpura
06/12/2014US20140161736 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
06/12/2014US20140161733 Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque
06/12/2014US20140161731 3,6-disubstituted xanthylium salts
06/12/2014US20140161722 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
06/12/2014US20140161720 Treatment of angiogenic- or vascular-associated diseases
06/11/2014EP2740798A1 Cancer treatment and/or prevention drug composition
06/11/2014EP2740742A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene
06/11/2014EP2740492A1 Triazine formulations with a second active ingredient and surfactant(s)
06/11/2014EP2740490A1 Treatment of proliferative disorders using antibodies to PSMA
06/11/2014EP2740489A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
06/11/2014EP2740475A1 Left ventricular diastolic function improving agent
06/11/2014EP2739281A1 Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance
06/11/2014EP2739276A1 Antiseptic composition
06/11/2014EP2739275A1 Antiseptic composition
06/11/2014CN103857411A Methods and compositions for treating asthma using anti-il-13 antibodies
06/11/2014CN103857392A 2 - carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases
06/11/2014CN103845735A Gel of complexone metal complex as well as preparation method and use thereof
06/11/2014CN103845734A Esomeprazole pharmaceutical composition and preparation thereof
06/11/2014CN103845733A Novel application of PTP1B (protein tyrosine phosphates 1b) inhibitor
06/11/2014CN103845724A Methods for the prevention or treatment of heart failure
06/11/2014CN103143020B Pharmaceutical composition for treating hypertensive left ventricular hypertrophy and application thereof
06/11/2014CN102716087B Vitamin powder and preparation method thereof
06/11/2014CN102702453B pH-responsive 6-arm star block copolymer and preparation method and application thereof
06/11/2014CN102183655B New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer
06/11/2014CN102058888B Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof
06/10/2014US8748425 Combination of brimonidine and timolol for topical ophthalmic use
06/10/2014US8748414 Statin nanoparticles
06/10/2014US8748413 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
06/10/2014US8748408 Methods of treatment of mitochondrial disorders
06/10/2014US8748116 1L1RL-1 as a cardiovascular disease marker and therapeutic target
06/10/2014US8747889 Transdermal analgesic systems with reduced abuse potential
06/10/2014US8747857 Calicheamicin derivative-carrier conjugates
06/10/2014US8747467 Muscle-based grafts/implants
06/10/2014CA2705836C Treatment of oral pharyngeal dysphagia
06/10/2014CA2562871C Iron based compounds for elastogenesis and connective tissue treatment
06/10/2014CA2482634C Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
06/10/2014CA2399280C Defects in periaxin associated with myelinopathies
06/05/2014WO2014085523A1 Methods of modulating follicle stimulating hormone activity
06/05/2014WO2014085471A1 Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
06/05/2014WO2014085381A1 Pharmaceutical combinations
06/05/2014WO2014085362A1 Methods for the treatment of parkinson's disease psychosis using pimavanserin
06/05/2014WO2014085318A1 Combination therapy
06/05/2014WO2014084401A1 Medical patch
06/05/2014WO2014084378A1 Anticancer drug comprising cyclic rgd sequence-containing peptide
06/05/2014WO2014084085A1 Prophylactic/therapeutic agent for hearing disorder or cerebellar ataxia
06/05/2014WO2014083567A2 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
06/05/2014WO2014083557A1 Compositions for the treatment of rosacea
06/05/2014WO2014083099A1 A method of inhibiting the expression of il-22 in activated t-cells
06/05/2014WO2014083026A1 Inhibitors of bruton's tyrosine kinase
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 1151